Tirelli U, Franchin G, Crivellari D, Veronesi A, Galligioni E, Trovó M G, Talamini R, Tumolo S, Grigoletto E
Am J Clin Oncol. 1984 Oct;7(5):451-2. doi: 10.1097/00000421-198410000-00011.
A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.
VM 26在实体瘤中的显著活性已在脑肿瘤、膀胱癌和神经母细胞瘤中得到证实。在乳腺癌中的初步良好结果促使我们机构开展了一项II期研究,以确定VM 26在晚期、均一预处理乳腺癌患者中的活性。